References

American College of Radiology (ACR). Illustrated breast imaging reporting and data system (BI-RADS^TM. 3nd ed. Reston [VA]: American College of Radiology, 1998.

Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, eds. Manual for Staging of Cancer, 4th ed. Philadelphia: JB Lippincott, 1992; 149-154.

Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24740 breast cancer cases. Cancer 1989; 63:181-187.

Cody HS III, Laughlin EH, Trillo C et al. Have changing treatment patterns affected outcome for operable breast cancer? Ten year follow-up in 1288 patients, 1965-1978. Ann Surg 1991; 213:297-307.

Silverstein MJ, Gierson ED, Waisman JR et al. Axillary lymph node dissection for T1a breast carcinoma: is it indicated? Cancer 1994; 73:664-667.

Mustafa IA, Cole B, Wanebo HJ et al. The impact of histopathology on nodal metastases in minimal breast cancer. Arch Surg 1997; 132:384-391.

Port ER, Tan LK, Borgen PI et al. Incidence of axillary lymph node metastases in T1a and T1b breast carcinoma. Ann Surg Onc 1998; 5:23-27.

Kopans DB. Breast Imaging, 2nd ed. Philadelphia: Lippincott-Raven Publishers, 1998

Kopans DB, ed. Health Effects of Exposure to Low Levels of Ionizing Radiation: BEIR V. Washington, DC: National Academy Press, 1990.

Kopans DB. Breast Imaging, 2 1998; 105.

Feig SA, Hendrick RE. Radiation risk from screening mammography of women aged 40-49 years. Monogr Natl Cancer Inst 1997; 22:119-124.

Shapiro S. Evidence on screening for breast cancer from a randomized trial. Cancer 1977; 39:2772-2782.

Shapiro S, Venet W, Strax P et al. Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982; 69:349-355.

Shapiro S. Periodic screening for breast cancer: the HIP randomized controlled trial. Monogr Natl Cancer Inst 1997; 22:27-30.

Baker LH. Breast cancer detection demonstration project: five-year summary report. CA 1982; 32:194-225.

Seidman H, Gelb SK, Silverberg E et al. Survival experience in the breast cancer detection demonstration project. CA Cancer J Clin 1987; 37:258-290.

Kopans DB, ed. The breast cancer screening controversy and the National Institutes of Health Consensus Development Conference on Breast Cancer Screening for Women Ages 40-49. Radiology 1999; 210: 4-9.

Hendrick RE, Smith RA, Rutledge JH, Smart CR. Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. Monogr Natl Cancer Inst 1997; 22: 87-92.

American College of Radiology (ACR). ACR Standard for the Performance of Screening Mammography. Reston [VA]: American College of Radiology; 1998: 37-41.

Leitch AM, Dodd GD, Costanza M et al. American Cancer Society Guidelines for the Early Detection of Breast Cancer: Update 1997. CA Cancer J Clin 1997; 47:150-153.

National Cancer Institute.

Dershaw DD. Questions and Answers. AJR 1999; 172: 1136.

Anderson BO, Senie RT, Vetto JT et al. Improved survival in young women with breast cancer. Ann Surg Oncol 1995; 2:407-415.

Dershaw DD, Yahalom J, Petrek JA. Breast carcinoma in women previously treated for Hodgkin Disease: mammographic evaluation. Radiology 1992; 184:421-423.

Burke W, Daly M, Garber J et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer: II. BRCA1 and BRCA2. JAMA 1997; 277:997-1003.

Burhenne LJW, Hislop TG, Burhenne HJ. The British Columbia Mammography Screening Program: Evaluation of the First 15 Months. AJR 1992; 158:45-49.

Robertson CL. A private breast imaging practice: medical audit of 25,788 screening and 1,077 diagnostic examinations. Radiology 1993; 187:75-79.

Sickles EA. Quality assurance: how to audit your own mammography practice. Rad Clin N America 1992; 30:265-275.

Rosenberg RD, Lando JF, Hunt WC et al. The New Mexico Mammography Project. Screening mammography performance in Albuquerque, New Mexico, 1991 to 1993. Cancer 1996; 78:1731-1739.

Brown ML, Houn F, Sickles EA et al. Screening mammography in community practice: positive predictive value of abnormal findings and yield of follow-up diagnostic procedures. AJR 1995; 165:173-177.

Thurfjell E. Population-based mammography screening in clinical practice: results from the prevalence round in Uppsala County. Acta Radiol 1994; 35:487-491.

Elmore JG, Barton MB, Moceri VM et al. Ten-year risk of false positive screening mammograms and clinical breast exams. N Engl J Med 1998; 338:1089-1096.

Jackson VP. The current role of ultrasonography in breast imaging. Radiologic Clinics of North America 1995; 33:1161-1170.

Stavros AT, Thickman D, Rapp CL et al. Solid breast nodules: Use of sonography to distinguish between benign and malignant lesions. Radiology 1995; 196:123-134.

Morris EA, Schwartz LH, Dershaw DD et al. MR imaging of the breast in patients with occult primary breast carcinoma. Radiology 1997; 205:437-440.

Harms SE, Flamig DP, Hesley KL et al. MR imaging of the breast with rotating delivery of excitation off resonance: Clinical experience with pathologic correlation. Radiology 1993; 187:493-501.

Orel SG, Hochman MC, Schnall MD et al. High-resolution MR imaging of the breast: Clinical context. RadioGraphics 1996; 16:1385-1401.

Orel SG, Schnall MD, Powell CM et al. Staging of suspected breast cancer: Effect of MR imaging and MR-guided biopsy. Radiology 1995; 196:115-122.

Solomon B, Orel S, Reynolds C et al. Delayed development of enhancement in fat necrosis after breast conservation therapy: A potential pitfall of MR imaging of the breast. AJR 1998; 170:966-968.

Gordon PB, Goldenberg SL. Malignant breast masses detected only by ultrasound: A retrospective review. Cancer 1995; 76:626-630.

Kolb TM, Lichy J, Newhouse JH. Occult cancer in women with dense breasts: detection with screening US - diagnostic yield and tumor characteristics. Radiology 1998; 207:191-199.

Slanetz PJ, Edmister WB, Weisskoff RM et al. Occult contralateral breast cancer detected by breast MR. Radiology 1998; 209(P):467.

Liberman L, Abramson AF, Squires FB et al. The Breast Imaging Reporting and Data System: positive predictive value of mammographic features and final assessment categories. AJR 1998; 171:35-40.

Sickles EA. Periodic mammographic follow-up of probably benign lesions: results in 3,184 consecutive cases. Radiology 1991; 179:463-468.

Sickles EA. Nonpalpable, circumscribed, noncalcified solid breast masses: likelihood of malignancy based on lesion size and age of patient. Radiology 1994; 192:439-442.

Varas X, Leborgne F, Leborgne JH. Nonpalpable, probably benign lesions: role of follow-up mammography. Radiology 1992; 184:409-414.

Orel SG, Sullivan DC, Dambro TJ. BI-RADS™ categorization as a predictor of malignancy (abstr). Radiology 1997; 205 (P):447.

Dershaw DD. Needle localization for breast biopsy. In: Dershaw DD, ed. Interventional Breast Procedures. New York: Churchill Livingstone, 1996:25-35.

Helvie MA, Ikeda DM, Adler DD. Localization and needle aspiration of breast lesions: Complications in 370 cases. AJR 1991; 157:711-714.

Whitman GJ, McCarthy KA, Hall DA et al. Retained hook-wire fragments in 12 patients: Mammography and management (abstr). Radiology 1993; 189 (P):326.

Jackman RJ, Marzoni FA. Needle-localized breast biopsy: why do we fail? Radiology 1997; 204:677-684.

Liberman L. Advantages and disadvantages of minimally invasive breast biopsy procedures. In: Parker SH, ed. Interventional Breast Procedures. In: Feig SA, ed. Seminars in Breast Disease 1998; 1: 84-94.

Liberman L. Stereotaxic biopsy technique. In: Dershaw DD, ed. Interventional Breast Procedures. New York: Churchill Livingstone, 1996; 107-127.

Parker SH, Jobe WE, Dennis MA et al. US-guided automated large-core biopsy. Radiology 1993; 187:507-511.

Liberman L, Feng TL, Dershaw DD et al. US-guided core breast biopsy: use and cost-effectiveness. Radiology 1998; 208:717-723.

Parker SH, Burbank F, Jackman RJ et al. Percutaneous large-core breast biopsy: a multi-institutional study. Radiology 1994; 193:359-364.